Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed knee pain requiring chondroplasty knee arthroscopic surgery.~* Men and non-pregnant, non-lactating women over the age of 18 and under the age of 75, able to read, understand and sign English-language informed consent.~* If using psychoactive medication which might have analgesic effects, (i.e. anti-depressants or anti-consultants), treatment must be stable for at least three (3) months prior to study.~* For men and women of child-bearing potential, must be willing to use adequate contraception and not be pregnant or impregnate their partner during the entire time of study.~* Must be willing to commit to all clinical visits during study-related procedures.~* Require use of narcotics for pain relief.~Exclusion Criteria:~* Patients with significant neurologic impairment, as diagnosed on screening physical examination.~* Patients not fluent in English.~* Patients currently involved in a Workman's Compensation case related to this procedure.~* Receipt of an oral intramuscular or soft-tissue injection of corticosteroid within one (1) month prior to screening.~* History of substance abuse.~* History of malignancy, other than basal or squamous cell of the skin within the last 5 years.~* Tibial plateau fracture within 6 months prior to surgery.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Theramine (Type: ACTIVE_COMPARATOR): Theramine 2 capsules three times per day in addition to post surgical analgesic medication.
- Theramine-like Placebo (Type: PLACEBO_COMPARATOR): Theramine-like placebo 2 capsules three times per day in addition to post surgical analgesic medication.

Based on this trial design, predict the completion outcome and termination type (if applicable).